On World No-Tobacco Day, Union Health Ministry releases OTT guidelines for regulation of online depiction of Tobacco Products in online curated content
On World No-Tobacco Day, Union Health Minister, Dr Mansukh Mandaviya released OTT guidelines for regulation of online depiction of Tobacco Products in online curated content, in the presence of Shri S. Singh Baghel, Minister of State for Health & Family Welfare. Publishers of online curated content that display tobacco products or their use will be […]
5 Crore hospital admissions authorized under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana
Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) achieved a milestone of 5 crore hospital admissions amounting to Rs 61,501 crore under the scheme. The flagship scheme being implemented by the National Health Authority (NHA) provides health cover of Rs. 5 lakhs per family per year for secondary and tertiary care hospitalization to 12 […]
Disease Outbreak News (DON): Enterovirus Infection – France
On 5 May 2023, France reported an increase in cases of severe neonatal sepsis associated with Enterovirus (Echovirus-11 (E-11)). A total of nine cases of neonatal sepsis with hepatic impairment and multi-organ failure were reported between July 2022 and April 2023 from four hospitals in three regions of France. As of 5 May 2023, seven […]
Union Health Minister Dr Mansukh Mandaviya addresses roundtable conference with leading CEOs of Pharmaceutical industry
Union Minister of Chemicals and Fertilizers, and Health and Family Welfare Dr Mansukh Mandaviya chaired a roundtable meeting with the leading CEOs of pharmaceutical industry in the country on the second day of 8th International Conference on Pharma and Medical Device Sector, here today. Ms. S Aparna, Secretary, Department of Pharmaceuticals was also present. Lauding […]
WHO urges governments to stop subsidizing life-threatening tobacco crops
On World No Tobacco Day, the World Health Organization (WHO) urges governments to stop subsidizing tobacco farming and support more sustainable crops that could feed millions. “Tobacco is responsible for 8 million deaths a year, yet governments across the world spend millions supporting tobacco farms,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “By choosing to […]
76th World Health Assembly
Union Minister of Health and Family Welfare Dr. Mansukh Mandaviya, delivered the Keynote Address at a Quad Plus Side Event on Tuberculosis(Tb) during the 76th World Health Assembly being held in Geneva. The event witnessed the participation of distinguished delegates from Quad Plus countries, reinforcing the commitment to tackle the global health challenge posed by […]
WHO calls for safe and ethical AI for health
The World Health Organization (WHO) is calling for caution to be exercised in using artificial intelligence (AI) generated large language model tools (LLMs) to protect and promote human well-being, human safety, and autonomy, and preserve public health. LLMs include some of the most rapidly expanding platforms such as ChatGPT, Bard, Bert and many others that […]
WHO congratulates Benin and Mali for eliminating trachoma as a public health problem
WHO has validated Benin and Mali as having eliminated trachoma as a public health problem, making them the fifth and sixth countries in WHO’s African Region to achieve this significant milestone. Countries that previously received WHO validation for trachoma elimination are Ghana (June 2018), Gambia (April 2021), Togo (May 2022) and Malawi (September 2022). “WHO […]
Myocarditis - United Kingdom of Great Britain and Northern Ireland
On 5 April 2023, the National IHR Focal Point for the United Kingdom informed WHO of an increase in severe myocarditis in neonates and infants associated with enterovirus infection in Wales compared with 2021. Between June 2022 and March 2023, 15 neonates and young infants presented with a picture consistent with neonatal sepsis in Wales […]
Roche’s BTK inhibitor fenebrutinib significantly reduced brain lesions in people with relapsing forms of multiple sclerosis
Fenebrutinib is an investigational, potent and highly selective oral Bruton’s tyrosine kinase (BTK) inhibitor, the only reversible BTK inhibitor currently in Phase III multiple sclerosis (MS) trials Phase II study met its primary and secondary endpoints by reducing the total number of new gadolinium-enhancing T1 brain lesions and significantly reducing the total number of new […]
